Clinical Trials
14 trialsNCT00904410 2026-03-13
CHIMTEP
Centre Oscar Lambret
Phase 4 Completed
NCT04401059 2023-12-27
SELECT-2
Hangzhou Normal University
Phase 4 Unknown
NCT02335151 2019-12-13
CTC Pancreatic Adenocarcinoma
University of Zurich
Phase 4 Completed
NCT02151149 2018-09-24
ABOUND 70+
Celgene
Phase 4 Completed
NCT01665417 2017-02-08
Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung Adenocarcinoma
Betta Pharmaceuticals Co., Ltd.
Phase 4 Unknown
NCT01701310 2016-10-28
IVICA
Nottingham University Hospitals NHS Trust
Phase 4 Completed
NCT01927328 2016-10-28
IRON
Nottingham University Hospitals NHS Trust
Phase 4 Unknown
NCT01180452 2015-06-23
DYDJI
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
Phase 4 Completed
NCT02103257 2015-04-29
Sequential Icotinib Plus Chemotherapy Versus Icotinib Alone as First-line Treatment in Stage IIIB/IV Lung Adenocarcinoma
Betta Pharmaceuticals Co., Ltd.
Phase 4 Unknown
NCT02194556 2014-07-18
Sequential and Maintenance Icotinib Plus Chemotherapy Versus Icotinib Maintenance After Chemotherapy in Advanced NSCLC
Betta Pharmaceuticals Co., Ltd.
Phase 4 Unknown
NCT01365143 2014-06-02
Prospective Randomized Trial Comparing Robotic Versus Open Radical Prostatectomy
Mayo Clinic
Phase 4 Terminated
NCT02057471 2014-02-07
Intravenous Iron: Measuring Response in Anemic Surgical Patients
Nottingham University Hospitals NHS Trust
Phase 4 Completed
NCT01579721 2013-02-05
Prospective Randomized Study of SILS Versus CLS for Rectal Cancer
Hvidovre University Hospital
Phase 4 Completed
NCT00844675 2012-10-18
Effects of Oral Rabeprazole on the Prevention of Ulcer Bleeding Following Endoscopic Mucosal Resection
The Catholic University of Korea
Phase 4 Completed